Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYT14P1, or Synaptotagmin 14 pseudogene 1, is classified as a pseudogene that is similar in sequence to the protein-coding gene Synaptotagmin 14 (SYT14) but does not code for a functional protein. Pseudogenes such as SYT14P1 generally arise from duplication or retrotransposition events and typically lack known biological function or disease association. SYT14P1 has several alternative names, and there is a functional, protein-coding SYT14 gene, but SYT14P1 itself is not considered a therapeutic target and does not serve as a receptor, enzyme, transporter, or other actionable molecular entity in biomedical research or drug development. Most available data and clinical relevance (including associations with spinocerebellar ataxia) pertain to the functional SYT14 gene, not SYT14P1. For SYT14P1, there are no established biological functions, disease roles, or drug interactions. If information was intended for the protein-coding synaptotagmin 14 (SYT14), that target would have a distinct canonical name and profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptotagmin 14 pseudogene 1 (SYT14P1).